
Chemometec A/S
CSE:CHEMM

Intrinsic Value
The intrinsic value of one
CHEMM
stock under the Base Case scenario is
302.75
DKK.
Compared to the current market price of 519.5 DKK,
Chemometec A/S
is
Overvalued by 42%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Chemometec A/S
Fundamental Analysis


Revenue & Expenses Breakdown
Chemometec A/S
Balance Sheet Decomposition
Chemometec A/S
Current Assets | 490.9m |
Cash & Short-Term Investments | 264.7m |
Receivables | 88.9m |
Other Current Assets | 137.3m |
Non-Current Assets | 239.3m |
Long-Term Investments | 1.2m |
PP&E | 104.9m |
Intangibles | 133.2m |
Free Cash Flow Analysis
Chemometec A/S
DKK | |
Free Cash Flow | DKK |
Earnings Waterfall
Chemometec A/S
Revenue
|
459.5m
DKK
|
Cost of Revenue
|
-91.6m
DKK
|
Gross Profit
|
367.9m
DKK
|
Operating Expenses
|
-157.6m
DKK
|
Operating Income
|
210.3m
DKK
|
Other Expenses
|
-41.3m
DKK
|
Net Income
|
169.1m
DKK
|
CHEMM Profitability Score
Profitability Due Diligence
Chemometec A/S's profitability score is 78/100. The higher the profitability score, the more profitable the company is.

Score
Chemometec A/S's profitability score is 78/100. The higher the profitability score, the more profitable the company is.
CHEMM Solvency Score
Solvency Due Diligence
Chemometec A/S's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Score
Chemometec A/S's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CHEMM Price Targets Summary
Chemometec A/S
According to Wall Street analysts, the average 1-year price target for
CHEMM
is 665.55 DKK
with a low forecast of 636.3 DKK and a high forecast of 708.75 DKK.
Dividends
Current shareholder yield for CHEMM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CHEMM
stock under the Base Case scenario is
302.75
DKK.
Compared to the current market price of 519.5 DKK,
Chemometec A/S
is
Overvalued by 42%.